In recent months, the Food and Drug Administration and National Institutes of Health have announced new initiatives to reduce and replace animal testing in biomedical research. Central to these ...
Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near future.
The FDA has released new guidance reducing the need for animal testing in monoclonal antibody cancer drugs when human-based ...
Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...
The National Institutes of Health announced last week that it will no longer issue funding calls for grant proposals that rely solely on animal testing. Moving forward, all such calls must also ...
In April 2025, the U.S. Food and Drug Administration (FDA) released its Roadmap to Reducing Animal Testing in Preclinical Safety Studies—a landmark initiative that lays out a plan to make animal ...
The FDA has released a plan to stop or reduce the use of primates for testing the safety of certain monoclonal antibodies (mAbs), the latest expansion of the regulator’s efforts to eliminate animal ...
Testing products on animals became an industry standard in the cosmetic, chemical, and pharmaceutical industries nearly a century ago. Since that time, it has become clear that these tests cause ...
Criticism of animal research − usually associated with the progressive left − has grown in recent years, as the practice is blamed for the slow pace of drug development. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback